ストックスクリーナーアプリを入手
4.94
1.23%
0.06
アフターアワーズ：
4.82
-0.12
-2.43%
前日終値:
$4.88
開ける：
$4.75
24時間の取引高:
15,016
Relative Volume:
1.71
時価総額：
$11.06M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+4.00%
1か月 パフォーマンス:
+0.00%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$4.75
$5.00
1週間の範囲:
$4.59
$5.15
52週間の値動き範囲:
$4.0408
$5.75
Bio Green Med Solution Inc Stock (BGMS) Company Profile
名前
Bio Green Med Solution Inc
セクター
電話
908-517-7330
住所
200 CONNELL DRIVE, BERKELEY HEIGHTS
BGMS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BGMS
Bio Green Med Solution Inc
|
4.94 | 14.34M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Bio Green Med Solution Inc Stock (BGMS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-07-18 | 再開されました | Oppenheimer | Outperform |
| 2020-04-27 | 再開されました | ROTH Capital | Buy |
| 2018-09-07 | 開始されました | Ladenburg Thalmann | Buy |
| 2015-10-16 | 開始されました | H.C. Wainwright | Buy |
| 2010-02-04 | 開始されました | Roth Capital | Buy |
| 2009-10-28 | 開始されました | Merriman | Buy |
| 2008-08-12 | 開始されました | Piper Jaffray | Buy |
| 2008-03-12 | 繰り返されました | Cantor Fitzgerald | Buy |
| 2008-03-12 | 繰り返されました | Collins Stewart | Buy |
| 2008-03-12 | 繰り返されました | Needham & Co | Buy |
| 2007-11-27 | 繰り返されました | Cantor Fitzgerald | Buy |
| 2007-08-10 | 繰り返されました | Cantor Fitzgerald | Buy |
| 2007-06-04 | 繰り返されました | Needham & Co | Buy |
| 2007-04-23 | 開始されました | Lazard Capital | Buy |
| 2007-04-10 | 開始されました | Cantor Fitzgerald | Buy |
すべてを表示
Bio Green Med Solution Inc (BGMS) 最新ニュース
Biodexa Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:BDRX - Benzinga
Bio Green Med Solution Appoints New Independent Director - TipRanks
Cyclacel Pharmaceuticals: Recent Acquisition Completed - MSN
Bio Green Med Solution Faces Nasdaq Delisting Notice - TipRanks
BlackRock® Canada Announces Product Changes - The Manila Times
Inception Growth Acquisition Limited Announces Additional Contribution to Trust Account to Extend Business Combination Period - The Manila Times
Bio Green Med Solution announces closing of strategic acquisition of Fitters Sdn. Bhd. - MarketScreener
Bio Green Med Solution, Inc. Completes Acquisition of Fitters Sdn. Bhd. to Diversify Business Portfolio - Quiver Quantitative
Major Shareholder Cashes Out Big on Cyclacel Pharmaceuticals! - TipRanks
Cyclacel Pharmaceuticals Approves Key Shareholder Proposals - TipRanks
Cyclacel Pharmaceuticals shareholders approve share issuance and name change - Investing.com
Cyclacel Pharmaceuticals : Initial Statement of Beneficial Ownership (Form 3) - MarketScreener
Big Moves And Bigger Questions For Biotech And Tech Stocks - Finimize
Cyclacel Pharmaceuticals to Implement 1-for-15 Reverse Stock Split; Shares Fall - MarketScreener
Cyclacel Pharmaceuticals, Inc. announced that it has received $3 million in funding - MarketScreener
CYCLACEL PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT - MarketScreener
Fitters swaps fire safety arm for 19.99% stake in Nasdaq biotech firm - The Malaysian Reserve
Wacker Buys Manufacturing Assets and Know-how of Bio Med Sciences - CHEManager
Cyclacel Pharmaceuticals, Inc. Announces Chief Executive Officer Changes - MarketScreener
Cyclacel Pharmaceuticals Announces That Nasdaq Granted an Extension to Regain Compliance With the Equity Standard Rule - MarketScreener
Roth MKM Downgrades Cyclacel Pharmaceuticals(CYCC.US) to Hold Rating - 富途牛牛
Cyclacel Pharmaceuticals Confirms It Has Filed an Appeal to Nasdaq Staff Delisting Letter - MarketScreener
WACKER Positions itself as Solution Provider for Silicone-Coated Healthcare Products with New Acquisition - PR Newswire
Cyclacel Pharmaceuticals to Release First Quarter 2024 Financial Results - MarketScreener
Cyclacel Pharmaceuticals to Participate in 2024 BIO CEO and Investor Conference - MarketScreener
Cyclacel Pharmaceuticals Announces the Appointment of Brian Schwartz, M.D. as Chief Medical Officer - MarketScreener
Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update - MarketScreener
Cyclacel Pharmaceuticals Reports First Quarter Financial Results and Provides Business Update - MarketScreener
Cyclacel Pharmaceuticals Announces Receipt of $4.7 Million R&D Tax Credit - MarketScreener
Alaunos Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:TCRT - Benzinga
Waste biorefinery towards a sustainable circular bioeconomy: a solution to global issues - Biotechnology for Biofuels and Bioproducts
Cyclacel Pharmaceuticals Announces Management Changes - MarketScreener
Psyence Biomedical Stock Price, Quotes and Forecasts | NASDAQ:PBM - Benzinga
Cyclacel Pharmaceuticals Announces at-the-market $7 Million Strategic Investment by Fundamental Investor Acorn Bioventures - MarketScreener
Cyclacel Pharmaceuticals to Present at the Noble Capital Markets Investor Conference - MarketScreener
Bio Green Med Solution Inc (BGMS) 財務データ
Bio Green Med Solution Inc (BGMS) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
2.36%
1.10%
大文字化:
|
ボリューム (24 時間):